Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples